ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質、抗体、アッセイキット

タンパク質カタログ

輸入に関する法規制チェックは、御見積のご依頼をいただいた際に行います。
法規制によっては、定価として記載の価格に追加の費用が発生する場合や供給出来ない場合がございますので、あらかじめご了承ください。

サプライヤー
TargteMol
カタログNo.
TMPY-02078
製品名称
HtrA2/Omi Protein, Human, Recombinant (His)
タンパク質名
HtrA2/Omi
Species
Human
HOST
E. coli
100μg: -
お問い合わせ

Overview

Synonyms OMI, HtrA serine peptidase 2, PRSS25, PARK13
Characteristics Protease activity demonstrated by HtrA2 cleavage of bovine β-casein. Incubation of β-casein at 0.2 mg/mL with Recombinant Human HTRA-2 at 0.02 mg/mL (ratio of 10:1) for 60 minutes at 45℃ in 50 mM Tris, pH 8.0, which results in >95% cleavage of β-casein, as revealed by SDS-PAGE.
Endotoxin Level Please contact us for more information.
Purity 88%
Description Serine protease HTRA2, also known as high-temperature requirement protein A2, Omi stress-regulated endoprotease, Serine protease 25, Serine proteinase OMI and HTRA2, is a single-pass membrane protein that belongs to the peptidase S1B family. HTRA2 contains one PDZ (DHR) domain. HTRA2 is a serine protease that shows proteolytic activity against a non-specific substrate beta-casein. It promotes or induces cell death either by direct binding to and inhibition of BIRC proteins (also called inhibitor of apoptosis proteins, IAPs), leading to an increase in caspase activity or by a BIRC inhibition-independent, caspase-independent, and serine protease activity-dependent mechanism. HTRA2 cleaves THAP5 and promotes its degradation during apoptosis. Isoform 2 of HTRA2 seems to be proteolytically inactive. Defects in HTRA2 are the cause of Parkinson disease type 13 (PARK13) which is a complex neurodegenerative disorder characterized by bradykinesia, resting tremor, muscular rigidity, and postural instability, as well as by a clinically significant response to treatment with levodopa.
Reference Faccio L., et al., 2000, J. Biol. Chem. 275:2581-2588.,Strauss K.M., et al., 2005, Hum. Mol. Genet. 14:2099-2111.,Gray C.W., et al., 2000, Eur. J. Biochem. 267:5699-5710.,Suzuki Y., et al., 2001, Mol. Cell 8:613-621.
URL https://www.targetmol.com/recombinant-protein/htra2_omi_protein_human_recombinant_his_tag_

お問い合わせリスト(-)

お問い合わせフォーム